Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 1
2005 3
2006 3
2007 5
2008 3
2009 5
2010 1
2011 2
2012 2
2013 6
2014 9
2015 10
2016 7
2017 8
2018 9
2019 12
2020 12
2021 12
2022 12
2023 22
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
The role of Raptor in lymphocytes differentiation and function.
Tang J, Yang L, Guan F, Miller H, Camara NOS, James LK, Benlagha K, Kubo M, Heegaard S, Lee P, Lei J, Zeng H, He C, Zhai Z, Liu C. Tang J, et al. Among authors: zhai z. Front Immunol. 2023 May 22;14:1146628. doi: 10.3389/fimmu.2023.1146628. eCollection 2023. Front Immunol. 2023. PMID: 37283744 Free PMC article. Review.
The characterization of CD8+ T-cell responses in COVID-19.
Yang Y, Miller H, Byazrova MG, Cndotti F, Benlagha K, Camara NOS, Shi J, Forsman H, Lee P, Yang L, Filatov A, Zhai Z, Liu C. Yang Y, et al. Among authors: zhai z. Emerg Microbes Infect. 2024 Dec;13(1):2287118. doi: 10.1080/22221751.2023.2287118. Epub 2024 Jan 11. Emerg Microbes Infect. 2024. PMID: 37990907 Free PMC article. Review.
A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma.
Wang H, Fu BB, Wuxiao ZJ, Li YJ, Huang L, Ma J, Zhai ZM, Guo J, Wu YB, Xu ZS, Feng J, Zhou SS, Chen TT, Chen XG, Li GW, Liu TZ, Huang HB, Zheng RH, Li YH, Tao HF, Zi FM, Wu F, Wang J, Zeng H, Fu CB, Gale RP, Xia ZJ, Liang Y. Wang H, et al. Leukemia. 2022 Nov;36(11):2724-2728. doi: 10.1038/s41375-022-01679-x. Epub 2022 Aug 15. Leukemia. 2022. PMID: 35970944 No abstract available.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Song Y, Malpica L, Cai Q, Zhao W, Zhou K, Wu J, Zhang H, Mehta-Shah N, Ding K, Liu Y, Li Z, Zhang L, Zheng M, Jin J, Yang H, Shuang Y, Yoon DH, Gao S, Li W, Zhai Z, Zou L, Xi Y, Koh Y, Li F, Prince M, Zhou H, Lin L, Liu H, Allen P, Roncolato F, Yang Z, Kim WS, Zhu J. Song Y, et al. Among authors: zhai z. Lancet Oncol. 2024 Jan;25(1):117-125. doi: 10.1016/S1470-2045(23)00589-2. Epub 2023 Dec 9. Lancet Oncol. 2024. PMID: 38092009 Clinical Trial.
Immune dysregulation in primary immune thrombocytopenia patients.
Zhang J, Zhang Q, Li Y, Tao L, Wu F, Shen Y, Tao Q, Xu X, Wu C, Ruan Y, Wang J, Wang J, Wang Y, Zhai Z. Zhang J, et al. Among authors: zhai z. Hematology. 2018 Sep;23(8):510-516. doi: 10.1080/10245332.2018.1435021. Epub 2018 Feb 6. Hematology. 2018. PMID: 29409398 Clinical Trial.
137 results